| Overview |
| bsm-90124r-50µL |
| PAFAH1B1 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human LIS1 |
| 55-90/410 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5048 |
| P43034 |
| PAFAH1B1; Platelet Activating Factor Acetylhydrolase 1b Regulatory Subunit 1; LIS1; PAFAH; MDCR; MDS; Platelet-Activating Factor Acetylhydrolase 1b Regulatory Subunit 1 (45kDa); Platelet-Activating Factor Acetylhydrolase IB Subunit Beta; NudF; Platelet-Activating Factor Acetylhydrolase Isoform Ib Alpha Subunit (45kD); Platelet-Activating Factor Acetylhydrolase Isoform Ib Alpha Subunit 45kDa; Platelet-Activating Factor Acetylhydrolase Isoform Ib Subunit 1 (45kDa); Miller-Dieker Syndrome Chromosome Region; PAF Acetylhydrolase 45 KDa Subunit; Lissencephaly 1 Protein; Lissencephaly-1 Protein; PAF-AH 45 KDa Subunit; Lissencephaly-1; PAF-AH Alpha; PAFAH Alpha; PAFAHA; LIS-1; LIS2; NUDF |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |